A primigravida at 41 weeks gestation is admitted for labor induction due to post-term pregnancy. The cervix is 1 cm dilated, 50% effaced, and the fetal head is at -2 station. Which nursing intervention should be the priority when preparing for cervical ripening with misoprostol (Cytotec)?

With an unfavorable cervix (Bishop score less than 6), cervical ripening with prostaglandins like misoprostol is indicated before oxytocin induction to improve cervical readiness for labor.

Core Nursing Explanation Key Concept Analysis: This question assesses the priority nursing action before administering a cervical ripening agent, specifically misoprostol (Cytotec), in a post-term pregnancy. The core theme is patient safety, informed consent, and fetal surveillance. The patient's cervical status (1 cm, 50%, -2) indicates an unfavorable cervix with a low Bishop score, making cervical ripening a necessary precursor to labor induction. Misoprostol is a potent prostaglandin E1 analog that can cause Watch out for confusion! uterine tachysystole (excessive contractions) and potential fetal compromise.

Answer Rationale: Key Point! The priority intervention is Obtain informed consent and ensure continuous fetal monitoring is established (Option 4). This is the correct answer because it encompasses two critical safety steps. First, cervical ripening with misoprostol is an elective procedure with known risks (uterine hyperstimulation, fetal distress), requiring the patient's full understanding and consent. Second, continuous electronic fetal monitoring (EFM) is mandatory before and during prostaglandin administration to immediately detect any signs of fetal intolerance or abnormal uterine activity, which are potential emergencies.

Distractor Analysis:
• Watch out for confusion! Option 1 (Administer the misoprostol immediately) is incorrect and dangerous. Administering the medication without first ensuring informed consent and establishing continuous fetal monitoring violates patient autonomy and safety protocols. The nurse must complete the preparatory safety checks before drug administration.
• Option 2 (Insert an intrauterine pressure catheter (IUPC)) is incorrect and not the priority. An IUPC is used to measure the actual intensity of contractions in internal monitoring, typically after the membranes have ruptured or during active labor management. It is not a prerequisite for initiating cervical ripening. External tocodynamometry is sufficient and standard for monitoring uterine activity during this phase.
• Option 3 (Prepare for immediate cesarean delivery) is incorrect and represents a failure to understand the indication for cervical ripening. An unfavorable cervix at 41 weeks is precisely the reason to attempt cervical ripening and induction of labor, not an indication for immediate surgery. Cesarean delivery would only be considered if induction fails or if fetal or maternal complications arise.

Related Concepts: This scenario integrates knowledge of the Bishop score (assessing cervical favorability for induction), the mechanism of prostaglandins for cervical ripening, the nursing process (assessment and planning before implementation), and the legal/ethical principle of informed consent. Understanding that cervical ripening is a process that carries risk and requires vigilant monitoring is essential.
Concept Summary • Post-term Pregnancy: Gestation ≥ 42 weeks (this patient is at 41 weeks, approaching post-term, warranting induction). • Bishop Score: A system to predict the success of labor induction. Components: cervical dilation, effacement, station, consistency, and position. A score < 6 indicates an unfavorable cervix requiring ripening. • Cervical Ripening: The process of softening, thinning, and dilating the cervix before induction of labor. Methods include pharmacological (prostaglandins like misoprostol, dinoprostone) and mechanical (Foley catheter balloon). • Misoprostol (Cytotec): A prostaglandin E1 analog used off-label for cervical ripening and labor induction. It is contraindicated in patients with a previous cesarean delivery or major uterine surgery due to the risk of uterine rupture. • Nursing Priority: Safety first! Before administering any high-alert medication for induction/ripening, ensure: 1) Informed consent, 2) Baseline fetal assessment (Non-Stress Test/NST often required), 3) Continuous EFM in place.
Side-by-Side Comparison!

Intervention	Purpose & Timing	Nursing Priority Before Initiation
Cervical Ripening (e.g., Misoprostol)	To make an unfavorable cervix favorable for labor. Done before oxytocin induction.	Obtain consent, establish continuous EFM, verify no contraindications (e.g., prior uterine surgery).
Oxytocin (Pitocin) Induction/Augmentation	To stimulate uterine contractions after the cervix is favorable or labor has begun.	Establish continuous EFM, have IV access, titrate dose based on contraction pattern and fetal response.
Amniotomy (AROM)	To rupture membranes to augment labor or place internal monitors.	Assess fetal station (should be engaged), check for cord prolapse risk, document color/odor/amount of fluid.

Anatomy, Physiology & Pharmacology Points • Cervical Changes: Effacement is the thinning of the cervix (0% to 100%). Dilation is the opening of the cervical os (0 cm to 10 cm). Station refers to the level of the fetal presenting part relative to the ischial spines (-5 to +5). • Prostaglandin Mechanism: Misoprostol binds to prostaglandin receptors in the cervix, promoting collagen breakdown and water absorption, leading to softening (ripening). It also sensitizes the myometrium to oxytocin, potentially initiating contractions. • Fetal Monitoring: Continuous EFM allows assessment of the fetal heart rate (FHR) baseline, variability, and presence of accelerations or decelerations in response to uterine activity.
Memory Tips • Bishop Score Mnemonic: "D ESPC" - Dilation, Effacement, Station, Position, Consistency. Score < 6 = Needs Ripening. • Safety First for Induction: Think "Consent and Monitoring" before any "Meds" (CM before M). • Misoprostol Alert: Remember it's a high-alert medication in obstetrics. Contraindicated with uterine scars.
High-Frequency NCLEX Topics This integrates several high-yield NCLEX areas: Prioritization (Safety First), Pharmacology (High-Alert Medications), Fetal Assessment, and Legal/Ethical (Informed Consent). NCLEX loves to test the correct sequence of actions, especially what you do BEFORE administering a medication.
Watch Out for Question Variations! • Instead of asking for the priority intervention, a question might ask: "What is the nurse's responsibility before administering misoprostol?" or "The patient asks why she needs continuous monitoring. What is the nurse's best response?" (Answer: To ensure the baby tolerates the medication and to detect excessive contractions immediately). • The scenario could change to a patient with a previous cesarean delivery. The correct answer would then be to hold the misoprostol and notify the provider, as it is contraindicated.

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse admitting Maya, a 28-year-old primigravida at 41 weeks. Her cervix is long, closed, and posterior. The provider has ordered misoprostol 25 mcg intravaginally for cervical ripening. You enter the room to prepare her.

Nursing Intervention Strategy: 1. Assessment: Complete a thorough admission assessment, including a recent non-stress test (NST) result if available. Confirm the Bishop score details from the provider's exam. Assess the patient's understanding of the induction process and her anxiety level. 2. Nursing Diagnosis: Potential diagnoses include Risk for fetal injury related to potential uterine hyperstimulation from pharmacologic agent and Anxiety related to unfamiliar procedures and post-term pregnancy. 3. Planning & Implementation: • Priority Action: Sit with Maya and provide education about misoprostol—its purpose, how it's given, potential risks (cramping, tachysystole), and benefits. Use an interpreter if needed. Obtain her informed, written consent. • Apply the continuous external fetal monitor (EFM) belts. Obtain a 20-30 minute baseline strip showing a reactive NST (if not already done) and a quiet uterine activity tracing. • Only after consent is signed and the EFM is functioning properly, prepare the misoprostol dose per protocol (often a portion of a scored tablet). Administer it intravaginally as ordered, positioning the patient supine for 30 minutes afterward. • Document: Consent, pre-administration FHR and contraction pattern, exact time and dose of medication administered, and patient education provided. 4. Evaluation & Monitoring: Monitor FHR and uterine contractions continuously for at least 30-60 minutes after administration and per unit protocol (often every 15-30 minutes initially). Assess for signs of tachysystole (more than 5 contractions in 10 minutes) or non-reassuring FHR patterns. Report any abnormalities immediately. Reassess cervical status per provider orders, typically in 4-6 hours.

Patient Safety and Precautions: • Contraindication: Misoprostol is absolutely contraindicated in women with a history of prior cesarean delivery or major uterine surgery due to the significantly increased risk of uterine rupture. • Medication Caution: It is a high-alert medication. Double-check the order and dose with another nurse. The typical dose for cervical ripening is 25 mcg. Using higher doses (e.g., 100 mcg) intended for other purposes can cause catastrophic uterine hyperstimulation. • Key Monitoring Points: The primary dangers are uterine tachysystole and fetal bradycardia or late decelerations. Have oxygen, IV fluids, and terbutaline (a tocolytic to relax the uterus) readily available per unit policy.
Nursing Procedure & Medication Flow Procedure: Administering Vaginal Misoprostol for Cervical Ripening 1. Verify provider order, patient identity, and absence of contraindications. 2. Complete Patient Education and Obtain Informed Consent. 3. Apply continuous external fetal and uterine monitors. Obtain a 20-min baseline strip. 4. Perform hand hygiene, don gloves. 5. Prepare the correct dose (e.g., cut a 100 mcg tablet into quarters for 25 mcg). 6. Assist patient to dorsal recumbent position, drape for privacy. 7. Insert the tablet into the posterior vaginal fornix using a gloved finger. 8. Have patient remain supine for 30 minutes to prevent expulsion. 9. Initiate continuous monitoring per protocol (e.g., FHR and contractions every 15 min x 1 hr, then every 30 min). 10. Document all steps, findings, and patient response.

Emergency Response: Uterine Tachysystole with FHR Changes 1. Stop any ongoing oxytocin infusion if present. 2. Turn patient to left lateral position. 3. Administer oxygen via non-rebreather mask at 10-15 L/min. 4. Increase IV fluid rate (if no fluid restriction). 5. Notify provider STAT. 6. Prepare to administer terbutaline 0.25 mg subcutaneously or as ordered.
A Word from Your Senior Nurse "Nursing is not just about carrying out physician orders — it's about being the frontline guardian for your patients! In this scenario, your knowledge and actions are the primary safety system for both mom and baby. Rushing to give the misoprostol (Choice 1) might seem like 'following orders quickly,' but the professional nurse knows that the real priority is setting up the safety net first. That safety net is built on the patient's understanding (consent) and your ability to detect problems (monitoring). In clinical practice and on the NCLEX, always ask yourself: 'What needs to be in place to keep this patient safe BEFORE I start this intervention?' That mindset will make you a safe, trusted, and confident nurse."